BioPharm International
July 02, 2016
Perspectives on Outsourcing
29
7
CDMOs need to be aware that unfavorable public markets put emerging bio/pharma R&D spending at risk in 2017.
July 01, 2016
Features
29
7
Revised versions of ISO 14644 Parts 1 and 2 introduce changes to sampling procedures and monitoring plans for cleanrooms and clean zones.
July 01, 2016
Peer-Reviewed Research
29
7
The authors present an overview of the types of RNA-based therapeutics in existence and their optimal methods of manufacture, purification, formulation, and delivery.
July 01, 2016
Supply Chain
29
7
Recent trends in raw materials packaging may impact manufacturing, quality, and cost of biopharmaceuticals.
July 01, 2016
Troubleshooting
29
7
The author provides a review of the concepts of design and qualification that apply to single-use systems.
July 01, 2016
Cover Story
29
7
Capacity for complex therapeutics is become increasingly difficult to predict.
July 01, 2016
Features
29
7
Pressures to accelerate current and next-gen therapies are challenging traditional microbiological testing methods.
July 01, 2016
From the Editor
29
7
CPhI Pharma Awards seek nominations for excellence in biopharma development and manufacturing.
July 01, 2016
Product Spotlight
29
7
The ambr 250 mini benchtop bioreactor system from Sartorius Stedim Biotech can be used for parallel fermentation and cell culture.
July 01, 2016
Regulatory Beat
29
7
Agency guidance and industry standards aim to reduce lapses and improve quality operations.
July 01, 2016
Features
29
7
The author addresses critical issues to consider prior to performing forced degradation studies and provides best practice recommendations for these types of studies.
July 01, 2016
Issue PDF
29
7
Click the title above to open the BioPharm International July 2016 issue in an interactive PDF format.